Full Program | LNAM'09 Symposia

Full Program

Friday November 27th 2009

08:30-09:30   Registration + Coffee & croissant

09:30-09:45   Opening

09:45-10:45   Plenary lecture - Trevor Robbins

"Fractionating impulsivity: neuropsychiatric implications"

10:45-12:30   Short talks by Lemanic Neuroscientists (10 x 10’)


12:30-14:15   Sandwich Lunch + Poster session


14:15-16:00   Symposia (3x20' or 4x15' presentations + 45' round table)

16:00-16:30   Coffee break

16:30-17:45   Short talks by Lemanic Neuroscientists (7 x 10’)

17:45-18:45   Plenary lecture - Mathias Jucker

"The prion-aspect of Alzheimer´s disease"

18:45-19:00   Poster Prizes "Fonds Jean Falk-Vairant"

                     Closing remarks

19:00-20:00   Apèro in poster rooms

20:00-21:30   Dinner in hotel restaurant

21:30-23:00   DJ in hotel restaurant


LNAM'09 Symposia

1. Psychiatric Neuroscience


Pierre Magistretti (EPFL, UniL)
Dominique Muller (Unige-CMU)


14:15 Pierre Magistretti (EPFL): Strategies du bridge neuroscience and psychiatry
14:35 Dominique Muller (CMU, Unige): Synaptopathies in psychiatry
14:55 Alexandre Dayer (HUG): Neurodevelopmental pathways in psychiatry
15:15 Pierre Marquet (EPFL): Imaging plasticity in psychiatry
15:35 Martin Preisig (CNP, CHUV): Psychiatric epidemiology and neuroscience: a new challange for collaboration


2. Molecular and network regulation of sleep: from rodents to humans


Anita Lüthi (UniL-DBCM)
Michel Mühlethaler (Unige-CMU)
Mehdi Tafti (UniL-CIG)


14:15 Paul Franken (CIG, Unil): Genetic and sleep-wake dependent aspects of EEG slow-waves in mice
14:45 Pierre-Hervé Luppi (CNRS UMR, Lyon): The neuronal network of paradoxical (REM) sleep
15:15 Hans-Peter Landolt (Institute of Pharmacology and Toxicology, Univ. of Zurich): Genetic aspects of sleep-wake regulation in humans
15:45 Discussion


3. Neuroimaging

14:15 Richard Frackowiak (UniL-CHUV): Classifying brain images for medical research
14:35 Christoph Michel (Unige-CMU): Electrical neuroimaging in clinical and cognitive neuroscience
14:55 Jean-Philippe Thiran (EPFL): Towards global brain connectivity analysis by diffusion MRI
15:15 Rolf Gruetter (CIBM): MRI spectroscopy of the human brain
15:35 General Discussion


4. Synaptic mechanisms


Christian Lüscher (Unige-CMU)
Carl Petersen (EPFL)


14:15 Christian Lüscher (CMU, Unige): Synaptic mechanisms of drug addiction
14:45 Graham Knott (EPFL): The dynamics of neuronal structure
15:15 Carl Petersen: Synaptic mechanisms of sensory perception
15:45 General Discussion


5. Neurodegeneration


Patrick Fraering (EPFL)
Panteleimon Giannakopoulos (Unige)


14:15 Patrick C. Fraering (EPFL): Are the amyloid-beta peptides the sole causative agents of Alzheimer’s disease?
14:30 Panteleimon Giannakopoulos (UniGe): Identification of biological markers of cognitive decline: hopes and limits
14:45 Gabriel Gold (UniGe): Sorting out the clinical consequences of vascular burden in brain aging
15:00 Dirk Beher (Head of Neurobiology Merck Serono): Drug discovery for Neurodegenerative Diseases and its Challenge
15:15 Round table discussion


6. Neurorehabilitation and cerebral plasticity

Armin Schnider (Unige-HUG): Rehabilitation of motor function
Stephanie Clarke (UniL-CHUV): Rehabilitation of cognitive functions


7. Emotions: Everything you always wanted to know about the amygdala (and were never told)


Nouchine Hadjikhani (EPFL)
Patrik Vuilleumier (Unige-CMU)


14:15 David Sander (FAPSE): Neuropsychology of affective relevance in amygdala
14:45 Nouchine Hadjikhani (EPFL): The role of amygdala in autism
15:15 Patrik Vuilleumier (CMU & HUG): Attention and awareness in amygdala response
15:45 General Discussion


Follow us:      

Keynote speakers

Prof. Mathias Jucker

Hertie Institute for Clinical Brain Research, Dept. of Cellular Neurology, Tübingen, Germany

The prion-aspect of Alzheimer´s disease


At the Department of Cellular Neurology we are studying the cellular and molecular mechanisms reponsible for brain aging and the question why some people develop dementia at an advanced age. At the centre of our research is the most common and severe form of dementia, Alzheimer's disease. The pathological hallmarks are misfolded proteins which form so-called amyloid plaques and neurofibrillary tangles in the brain of the patients and irreversably destroy brain cell tissue.

We have succeeded in generating mouse models which develop these lesions and thus mimic the disease process in humans. First promising experiments to prevent amyloid deposits in the brains of these mice have taken us one important step closer to a possible Alzheimer therapy.


Prof. Trevor Robbins

Department of Experimental Psychology, University of Cambridge, UK

Fractionating impulsivity: neuropsychiatric implications


Trevor Robbins was appointed in 1997 as the Professor of Cognitive Neuroscience at the University of Cambridge. He was elected to the Chair of Expt. Psychology (and Head of Department) at Cambridge from October 2002. He is also Director of the newly-established Cambridge MRC Centre in Behavioural and Clinical Neuroscience, the main objective of which is to inter-relate basic and clinical research in Psychiatry and Neurology for such conditions as Parkinson’s, Huntington’s, and Alzheimer’s diseases, frontal lobe injury, schizophrenia, depression, drug addiction and developmental syndromes such as attention deficit/hyperactivity disorder.

He has been included on a list of the 100 most cited neuroscientists by ISI. He has published nearly five hundred full papers in scientific journals and has co-edited three books (Psychology for Medicine: The Prefrontal Cortex; Executive and Cognitive Function, and Disorders of Brain and Mind).


FBM Doctoral School - Amphipôle 316 - CH-1015 Lausanne
Tel. +41 21 692 40 14
Centre Hospitalier Universitaire Vaudois (CHUV) Hôpitaux Universitaires de Genève (HUG) Université de Genève Université de Lausanne École polytechnique fédérale de Lausanne (EPFL)